KPIs & Operating Metrics(New)

Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Amortization of Goodwill Amortization of Goodwill Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Receivables Change in Receivables Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Divestments Dividends Paid - Common Dividends Paid - Common Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Preferred Shares Issued Share-based Compensation Share-based Compensation Shares Issued

Daily Values

Growth Metrics

Evolent Health (EVH) Divestments (2021 - 2025)

Evolent Health has reported Divestments over the past 5 years, most recently at $198000.0 for Q3 2025.

For Q3 2025, Divestments changed N/A year-over-year to $198000.0; the TTM value through Dec 2025 reached $198000.0, up 2728.57%, while the annual FY2025 figure was $986000.0, 13985.71% up from the prior year.
Divestments for Q3 2025 was $198000.0 at Evolent Health, up from $7000.0 in the prior quarter.
Over five years, Divestments peaked at $43.0 million in Q1 2021 and troughed at -$33.6 million in Q2 2021.
A 5-year average of $5.8 million and a median of $786000.0 in 2023 define the central range for Divestments.
On a YoY basis, Divestments climbed as much as 161.25% in 2022 and fell as far as 487.83% in 2022.
Year by year, Divestments stood at $28.8 million in 2021, then dropped by 6.89% to $26.8 million in 2022, then tumbled by 99.74% to $71000.0 in 2023, then crashed by 90.14% to $7000.0 in 2024, then surged by 2728.57% to $198000.0 in 2025.
Business Quant data shows Divestments for EVH at $198000.0 in Q3 2025, $7000.0 in Q2 2024, and $71000.0 in Q3 2023.